Endometrial Cancer

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about better patient education in endometrial cancer patients.

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about racial disparities in endometrial cancer.

  Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about obesity in endometrial cancer patients.

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about recent advancements in endometrial cancer care.

Rates of early death from gynecologic cancers were higher among Black women compared with women of other races and ethnicities, recent data show.

Polycystic ovary syndrome presents in many forms with many manifestations, which is why providers must work with patients to treat the condition while factoring in their preferences and top concerns.

Transvaginal ultrasonography triage resulted in misclassification for more than one in 10 Black women, suggesting it is not a reliable strategy to identify Black women at risk for endometrial cancer, according to a diagnostic study.

The FDA approved the use of durvalumab in combination with carboplatin and paclitaxel followed by single-agent durvalumab for women with mismatch repair-deficient primary advanced or recurrent endometrial cancer.

Most phase 2/phase 3 oncology clinical trials do not report American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander racial categories in their studies, according to findings published in JAMA Health Forum.

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.